Thermo Fisher Scientific Inc. (TSX:TMO)
Canada · Delayed Price · Currency is CAD 24.22
+0.10 (0.41%)
Sep 29, 2026, 3:59 PM EST
Thermo Fisher Scientific Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 356,745 | 298,498 | 286,312 | 270,838 | 293,690 | 332,729 | |
Market Cap Growth | 45.95% | 4.26% | 5.71% | -7.78% | -11.73% | 41.45% |
Enterprise Value | 411,564 | 342,744 | 328,002 | 309,692 | 329,446 | 344,984 |
Last Close Price | 24.22 | 21.08 | 19.22 | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 36.09 | 32.47 | 31.41 | 34.21 | 31.22 | 34.04 |
PS Ratio | 5.43 | 4.89 | 4.64 | 4.79 | 4.83 | 6.71 |
PB Ratio | 4.76 | 4.07 | 4.01 | 4.38 | 4.92 | 6.42 |
P/FCF Ratio | 34.36 | 34.60 | 27.38 | 29.61 | 31.40 | 38.73 |
P/OCF Ratio | 27.90 | 27.85 | 22.96 | 24.40 | 23.71 | 28.24 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 6.26 | 5.61 | 5.32 | 5.47 | 5.42 | 6.95 |
EV/EBITDA Ratio | 23.79 | 22.44 | 21.04 | 21.86 | 20.39 | 21.03 |
EV/EBIT Ratio | 33.15 | 29.91 | 29.50 | 32.03 | 28.44 | 26.28 |
EV/FCF Ratio | 39.64 | 39.72 | 31.37 | 33.85 | 35.22 | 40.15 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.81 | 0.76 | 0.66 | 0.78 | 0.82 | 0.89 |
Debt / EBITDA Ratio | 3.48 | 3.51 | 2.90 | 3.28 | 2.92 | 2.74 |
Debt / FCF Ratio | 5.81 | 6.49 | 4.51 | 5.30 | 5.23 | 5.35 |
Net Debt / Equity Ratio | 0.73 | 0.57 | 0.55 | 0.61 | 0.63 | 0.78 |
Net Debt / EBITDA Ratio | 3.28 | 2.76 | 2.51 | 2.67 | 2.31 | 2.46 |
Net Debt / FCF Ratio | 5.26 | 4.89 | 3.74 | 4.13 | 4.00 | 4.69 |
Asset Turnover | 0.43 | 0.43 | 0.44 | 0.44 | 0.47 | 0.48 |
Inventory Turnover | 4.89 | 5.05 | 4.99 | 4.81 | 4.86 | 4.31 |
Quick Ratio | 1.01 | 1.36 | 1.14 | 1.27 | 1.06 | 1.00 |
Current Ratio | 1.55 | 1.89 | 1.66 | 1.76 | 1.48 | 1.50 |
Return on Equity (ROE) | 13.51% | 13.02% | 13.13% | 13.09% | 16.35% | 20.47% |
Return on Assets (ROA) | 5.13% | 5.03% | 4.93% | 4.67% | 5.56% | 7.90% |
Return on Invested Capital (ROIC) | 8.84% | 9.59% | 9.19% | 9.49% | 10.75% | 15.17% |
Return on Capital Employed (ROCE) | 9.00% | 8.80% | 9.20% | 8.60% | 10.70% | 12.70% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 2.77% | 3.08% | 3.18% | 2.92% | 3.20% | 2.94% |
FCF Yield | 2.91% | 2.89% | 3.65% | 3.38% | 3.19% | 2.58% |
Dividend Yield | 0.27% | 11.19% | 11.68% | - | - | - |
Payout Ratio | 9.50% | 9.49% | 9.20% | 8.72% | 6.55% | 5.11% |
Buyback Yield / Dilution | 1.45% | 1.31% | 1.29% | 1.52% | 0.76% | 0.50% |
Total Shareholder Return | 1.72% | 12.49% | 12.97% | 1.52% | 0.76% | 0.50% |